CIDRAP newsletters options
(CIDRAP News) President Barack Obama, giving a push to a proposal that has been in the works for years, yesterday ordered federal agencies to develop a plan for the US Postal Service (USPS) to deliver medical countermeasures to households in the wake of a biological attack.
(CIDRAP News) H1N1 flu patients who were also infected with a common cause of pneumonia were 125 times more likely to develop life-threatening disease, a team of American and Argentinean researchers reported Thursday.
Dec 30, 2009
(CIDRAP News) People living in the same household were less likely to catch H1N1 influenza from a sick family member than they would have been in past pandemics or during a normal flu season, a team from University College London and the Centers for Disease Control and Prevention report today in the New England Journal of Medicine.
(CIDRAP News) – Indonesia's Ministry of Health, updating information on H5N1 avian influenza for the first time since January, quietly reported this week that the country has had 20 human cases so far this year, with 19 of them fatal—a 95% case-fatality rate (CFR).
Dec 29, 2009
(CIDRAP News) – Health officials in New Hampshire are investigating whether a woman who is ill with gastrointestinal (GI) anthrax contracted the potentially deadly infection at a drum circle gathering in Durham, N.H.
Dec 28, 2009
(CIDRAP News) – Dr. Margaret Chan, director-general of the World Health Organization (WHO), said today that the H1N1 influenza pandemic isn't over and requires careful monitoring for up to another year.
(CIDRAP News) The US Food and Drug Administration (FDA) has approved a high-dose seasonal influenza vaccine for elderly people, whose aging immune systems may not respond effectively to flu vaccines intended for younger people.
The vaccine, Fluzone High-Dose, made by Sanofi Pasteur, contains four times as much antigen (active ingredient) as standard seasonal flu vaccines. The FDA and the company announced its approval Dec 23.
December 28, 2009
Dec 23, 2009
(CIDRAP News) Infection with H1N1 influenza poses a grave danger to pregnant women and those who have just delivered, and the risk increases when they do not receive antiviral treatment very rapidly, California and Atlanta researchers report today online ahead of print in the New England Journal of Medicine.
"This pandemic has the potential to notably increase overall maternal mortality in the United States in 2009," they write.
(CIDRAP News) The nation's supply of pandemic vaccine has grown to 111 million doses, enough so that the US Centers for Disease Control and Prevention (CDC) is turning part of its attention toward boosting the percentage of adults who get vaccinated.
Dec 22, 2009
(CIDRAP News) MedImmune Inc. today announced a recall of leftover doses from 13 lots of its nasal-spray H1N1 vaccine because of a slight loss of potency, but the company said those who received doses from the affected lots don't need to be revaccinated.
The company and the US Food and Drug Administration (FDA) said there are no safety problems with the recalled doses.
(CIDRAP News) – A study in Australia showed that one dose of H1N1 influenza vaccine, rather than the two doses recommended in the United States, was enough to generate a probably protective immune response in children younger than 9 years.
Dec 21, 2009
(CIDRAP News) Egypt's health ministry has confirmed an H5N1 avian influenza infection in a 21-year-old woman, the country's third case since late September, the World Health Organization (WHO) reported today.
